Tolerability of abiraterone (abi) combined with olaparib (ola) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Further results from the phase III PROpel trial.

Thiery-Vuillemin A., Saad F., Armstrong A. J., Oya M., Vianna K. C. M., Ozguroglu M., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.16, 2022 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 40 Issue: 16
• Publication Date: 2022
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• Istanbul University Affiliated: Yes